Venoarterial extracorporeal membrane oxygenation (VA ECMO) for acute heart failure in adultsStatus:In developmentProgramme:Interventional procedures guidanceExpected publication date: 15 October 2025
Digital platforms to support cardiac rehabilitation: early value assessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: 18 November 2025
Pulmonary artery pressure technologies for remote monitoring of chronic heart failureStatus:In developmentProgramme:Diagnostics guidanceExpected publication date: 20 January 2026
Venoarterial Extracorporeal membrane oxygenation (VA ECMO) for postcardiotomy cardiogenic shock in adultsStatus:In development | In consultationProgramme:Interventional procedures guidanceConsultation end date: 23 October 2025Expected publication date: 29 January 2026
Insertion of a catheter-based intravascular microaxial flow pump for cardiogenic shockStatus:In developmentProgramme:Interventional procedures guidanceExpected publication date: 25 March 2026
Artificial Intelligence assisted echocardiography to support diagnosis of heart failure: Early Value AssessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: 19 May 2026
Finerenone for treating heart failure with preserved or mildly reduced ejection fraction [ID6514]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 4 June 2026
Evolocumab for preventing major cardiovascular events in people aged 50 to 79 at high risk who have not had a myocardial infarction or stroke TS ID 11920Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC